相关实验视频
Updated: Jul 12, 2025

06:26
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
320
通过门门技术成功关闭透气管主动脉更换引起的Gerbode缺陷:一个案例报告
Ioannis Skalidis1,2, Michalis Hamilos1, Stylianos Petousis1
1Department of Cardiology, University Hospital of Heraklion, Crete, Greece.
概括
这项研究详细介绍了首次成功关闭透导管大动脉置换 (TAVR) 引起的Gerbode缺陷. 一种新的门技术有效地封闭了左心室到右心房的通信,提供了一个新的治疗选择.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 严重的大动脉狭窄是一种常见的需要干预的疾病.
- 过导管大动脉置换 (TAVR) 是对大动脉狭窄的标准治疗方法.
- 节缺陷是TAVR后可能出现的罕见但严重的并发症.
研究的目的:
- 报告第一个成功关闭TAVR诱导的Gerbode缺陷的记录案例.
- 描述门中的门方法作为这种并发症的潜在解决方案.
- 突出一种新的管理策略,以挑战TAVR并发症.
主要方法:
- 一名患有严重大动脉狭窄的90岁女性接受了TAVR.
- 扩张后导致血液动力学恶化,吸管,以及Gerbode缺陷 (左心室到右心室通信).
- 为稳定进行了心周凝聚,随后进行了第二个门的低植入 (门中的门).
主要成果:
- 门中的门程序成功地封闭了亚环裂和Gerbode缺陷.
- 患者的血液动力学稳定性得到恢复.
- 这种方法在管理罕见且具有挑战性的TAVR并发症方面被证明是有效的.
结论:
- 门中的门方法是管理TAVR诱导的Gerbode缺陷的可行和成功的策略.
- 这一案例扩大了治疗TAVR后罕见并发症的干预选择.
- 早期识别和迅速干预对于管理这种不良事件至关重要.
相关概念视频
Mitral Stenosis III: Medical Management
12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Aortic Regurgitation III: Medical Management
24
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
24
Aneurysm III: Interprofessional Care
9
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
9
Mitral Valve Prolapse II: Assessment and Management
19
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
19
Aortic Regurgitation I: Introduction
10
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
10
Mitral Regurgitation III: Medical Management
18
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
18

